Phakic intraocular lenses

Since Zaldivar's review of phakic intraocular lenses in these pages in 2000 [1**], further reports of experience with this technology have emerged. Their relative advantages and disadvantages over competing technologies are becoming clearer. Clinical trials, including Food & Drug Administra...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in ophthalmology Vol. 13; no. 1; p. 7
Main Authors Comaish, Ian F, Lawless, Michael A
Format Journal Article
LanguageEnglish
Published United States 01.02.2002
Subjects
Anterior Chamber - surgery
Biocompatible Materials
Clinical Trials as Topic
Humans
Lens Implantation, Intraocular - methods
Lens, Crystalline - physiology
Lenses, Intraocular
Refractive Surgical Procedures
Online AccessGet more information

Cover

More Information
Summary:Since Zaldivar's review of phakic intraocular lenses in these pages in 2000 [1**], further reports of experience with this technology have emerged. Their relative advantages and disadvantages over competing technologies are becoming clearer. Clinical trials, including Food & Drug Administration (FDA) trials, have shown predictability, stability, and efficacy. Safety of these implants over the long term remains a concern, but in some situations, at least, phakic intraocular lenses are becoming the refractive correction of choice. This brief review looks at the most recent data to emerge regarding phakic intraocular lenses.
ISSN:1040-8738
DOI:10.1097/00055735-200202000-00003